Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years: A pilot study among rural North Carolina clinics

While 9-valent human papillomavirus vaccination (HPV-9) is approved by the U.S. Food and Drug Administration for use in adolescents as young as age 9, providers typically recommend it at ages 11–12 per Centers for Disease Control and Prevention recommendations. Studies suggest that recommending HPV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Vielot, Nadja, Lane, Robyn M., Loefstedt, Kaitlyn, Cunningham, Jennifer, Everson, Jason, Tiller, Eli, Patel, Sallie, Smith, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915803/
https://www.ncbi.nlm.nih.gov/pubmed/36778244
http://dx.doi.org/10.21203/rs.3.rs-2326137/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915803/
https://www.ncbi.nlm.nih.gov/pubmed/36778244
http://dx.doi.org/10.21203/rs.3.rs-2326137/v1

Ejemplares similares